MoonLake Immunotherapeutics
Earnings Surprise
Analysts estimated MLTX earnings of $-1.01 per share this quarter (Q4). MLTX's actual earnings were $-0.92 per share.
MLTX EPS surprise of 9.03%Analysts estimated MLTX earnings of $-0.90 per share this quarter (Q3). MLTX's actual earnings were $-1.10 per share.
MLTX EPS surprise of -22.75%Analysts estimated MLTX earnings of $-0.74 per share this quarter (Q2). MLTX's actual earnings were $-0.87 per share.
MLTX EPS surprise of -18.25%Analysts estimated MLTX earnings of $-0.77 per share this quarter (Q1). MLTX's actual earnings were $-0.63 per share.
MLTX EPS surprise of 17.89%Analysts estimated MLTX earnings of $-0.61 per share this quarter (Q4). MLTX's actual earnings were $-0.72 per share.
MLTX EPS surprise of -18.11%Analysts estimated MLTX earnings of $-0.44 per share this quarter (Q3). MLTX's actual earnings were $-0.56 per share.
MLTX EPS surprise of -26.10%Analysts estimated MLTX earnings of $-0.28 per share this quarter (Q2). MLTX's actual earnings were $-0.39 per share.
MLTX EPS surprise of -37.91%Analysts estimated MLTX earnings of $-0.20 per share this quarter (Q1). MLTX's actual earnings were $-0.22 per share.
MLTX EPS surprise of -11.56%Analysts estimated MLTX earnings of $-0.23 per share this quarter (Q4). MLTX's actual earnings were $-0.12 per share.
MLTX EPS surprise of -48.89%Analysts estimated MLTX earnings of $-0.23 per share this quarter (Q3). MLTX's actual earnings were $-0.18 per share.
MLTX EPS surprise of -22.45%